• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER II; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER II; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Catalog Number UNK AMPLATZER DUCT OCCLUDER II
Device Problems Migration or Expulsion of Device (1395); Off-Label Use (1494)
Patient Problems Unspecified Infection (1930); Inflammation (1932); Pneumonia (2011); Sepsis (2067)
Event Date 03/01/2007
Event Type  Injury  
Event Description
The article, ¿amplatzer occluders for effective non-surgical management of bronchopleural fistulae¿, was reviewed.The article presented a retrospective single center study to assess the safety and efficacy of bronchopleural fistulae closure with amplatzer occluder devices over 14 years.Devices included in this study included amplatzer duct occluder ii and amplatzer vascular plug ii.The article concluded amplatzer occluders are a safe modality for non-surgical bronchopleural fistulae management with ease of placement under moderate sedation and flexible bronchoscopy with good short- and long-term effectivity.[(b)(6)].
 
Manufacturer Narrative
Summarized patient outcomes/complications of retrospective single center study to assess the safety and efficacy of bronchopleural fistulae closure with amplatzer duct occluder ii and amplatzer vascular plug ii devices over 14 years were reported in a research article "amplatzer occluders for effective non-surgical management of bronchopleural fistulae¿ in a subject population with multiple co-morbidities including malignant neoplasm of the lung, infection (post transplantation, lung abscess, mycobacterium, infection due to congenital anomaly, empyema), chronic obstructive pulmonary disease, granulomatosis with polyangiitis, malignant neoplasm of the esophagus, interstitial lung disease, cystic fibrosis, metastasis, hemoptysis, osler weber rendu, prior pneumonectomy, lobectomy, wedge resection.No procedural or immediate post-procedural complications or deaths were encountered.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17862555
MDR Text Key324823993
Report Number2135147-2023-04294
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER DUCT OCCLUDER II
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-